Bioprocessing White Papers

1. Containment Solutions To Help Emerging Biologic Companies Get Products To The Market Faster 3/24/2023

   Gain solutions on how to set up your small company for long-term success using packaging containment offerings and services to help mitigate risks and speed up your time to market.

2. Build Your Genome Engineering Toolbox For Success 3/22/2023

   Fast, efficient, and precise options for genome engineering are rapidly infiltrating the marketplace – the key to success is identifying the mechanism and tool(s) best suited for your goals.

3. How To Improve Resiliency In The Medical Device Supply Chain 3/21/2023

   Explore how to select the right partner in the medical device supply industry to avoid supply chain breakdowns in product quality, delivery or availability that could endanger patient health.

4. A Risk-Based Approach To The Development Of An Injectable Combination Product 3/14/2023

   Examine how to establish a holistic approach to drug-device combination product (DDCP) development and how to assess and manage risk throughout the development and approval process.

5. Host Cell Protein Analysis: Immunoassays 3/10/2023

   Learn about Host cell proteins (HCPs) and the sensitive and specific orthogonal methods necessary to identify individual HCP impurities that persist through DS purification processes.

6. Cultivate Innovation And Growth At Smart, Connected Facilities 3/6/2023

   As the US and Europe continue to lead the way in addressing a growing demand for health care products, explore how the global biotechnology sector is maintaining momentum and confronting future challenges.

7. Reliable Osmolality Testing Of High Concentration mAb Formulations 2/28/2023

   Review an evaluation of the OsmoTECH XT (freezing point) and Vapro 5600 (vapor pressure) osmometers as a means of measuring concentrated protein formulations.

8. Orthogonal Methods To Understand And Define CQAs Of AAV Therapies 2/24/2023

   An essential part of AAV vector production is the characterization of potential CQAs. Learn about novel, robust, and orthogonal methods that can be used to assess identity, purity, and residuals.

9. Match Your Development And Manufacturing Path To Your IND Milestones 2/17/2023

   The drug development journey is long, expensive, resource straining, and risky. Discover how to maximize the value of early phase material and match your development path to your IND milestones.

10. Manufacturing Of Cytotoxic And Non-Cytotoxic Drugs In A Multiproduct Facility 2/15/2023

    The experience and expertise of the CMO is crucial to avoid the risk of cross-contamination of the drug product, as failures or weaknesses in this process can pose risk to the end-user.